Treatment Innovations

CoreMap Secures $37M in Series C Funding to Revolutionize Atrial Fibrillation Mapping

• Treatment Innovations

CoreMap Secures $37M in Series C Funding to Revolutionize Atrial Fibrillation Mapping

Asep Darmawan July 30, 2026

In a significant move for the cardiovascular medtech sector, Massachusetts-based CoreMap has successfully closed a $37 million...

Read More Read more about CoreMap Secures $37M in Series C Funding to Revolutionize Atrial Fibrillation Mapping

GSK Unveils Massive £1.9 Billion Restructuring Plan to Counter Patent Cliff and Fuel Innovation

• Treatment Innovations

GSK Unveils Massive £1.9 Billion Restructuring Plan to Counter Patent Cliff and Fuel Innovation

Lina Irawan July 30, 2026

By Delilah Alvarado | July 28, 2026 In a decisive maneuver to insulate its future profitability from...

Read More Read more about GSK Unveils Massive £1.9 Billion Restructuring Plan to Counter Patent Cliff and Fuel Innovation

The Evolution of Oncology Intelligence: How ConcertAI is Transforming CancerLinQ into a Point-of-Care Powerhouse

• Treatment Innovations

The Evolution of Oncology Intelligence: How ConcertAI is Transforming CancerLinQ into a Point-of-Care Powerhouse

Layla Zulfa July 30, 2026

In the high-stakes world of oncology, the distance between a breakthrough discovery in a laboratory and the...

Read More Read more about The Evolution of Oncology Intelligence: How ConcertAI is Transforming CancerLinQ into a Point-of-Care Powerhouse

AI-Driven Diagnostic Breakthrough: CorVista Secures FDA Clearance for Non-Invasive Heart Failure Assessment

• Treatment Innovations

AI-Driven Diagnostic Breakthrough: CorVista Secures FDA Clearance for Non-Invasive Heart Failure Assessment

Azzam Bilal Chamdy July 30, 2026

In a significant leap forward for cardiovascular medicine, CorVista Health has received US Food and Drug Administration...

Read More Read more about AI-Driven Diagnostic Breakthrough: CorVista Secures FDA Clearance for Non-Invasive Heart Failure Assessment

Pharma Earnings Pulse: Biogen’s Resilience, AstraZeneca’s Ambitious Pivot, and GSK’s Oncology Bet

• Treatment Innovations

Pharma Earnings Pulse: Biogen’s Resilience, AstraZeneca’s Ambitious Pivot, and GSK’s Oncology Bet

Jia Lissa July 30, 2026

As the pharmaceutical industry navigates the midpoint of 2026, the latest quarterly earnings season offers a critical...

Read More Read more about Pharma Earnings Pulse: Biogen’s Resilience, AstraZeneca’s Ambitious Pivot, and GSK’s Oncology Bet

The Arms Race in Silicon: How Bristol Myers Squibb’s New AI Supercomputer Redefines Pharma Research

• Treatment Innovations

The Arms Race in Silicon: How Bristol Myers Squibb’s New AI Supercomputer Redefines Pharma Research

Neng Nana July 30, 2026

In the high-stakes world of pharmaceutical R&D, the battle for drug discovery supremacy has shifted from the...

Read More Read more about The Arms Race in Silicon: How Bristol Myers Squibb’s New AI Supercomputer Redefines Pharma Research

Elevation Spine Secures FDA Clearance for Saber-C AVIA: Advancing Cervical Fusion Technology

• Treatment Innovations

Elevation Spine Secures FDA Clearance for Saber-C AVIA: Advancing Cervical Fusion Technology

Laily UPN July 30, 2026

In a significant milestone for spinal orthopedics, Elevation Spine, a company renowned for its commitment to integrated-fixation...

Read More Read more about Elevation Spine Secures FDA Clearance for Saber-C AVIA: Advancing Cervical Fusion Technology

Beyond the AI Hype: How Verseon’s Physics-First Approach Challenges the Future of Drug Discovery

• Treatment Innovations

Beyond the AI Hype: How Verseon’s Physics-First Approach Challenges the Future of Drug Discovery

Nana July 29, 2026

In the rapidly evolving landscape of pharmaceutical research, the term "AI-driven drug discovery" has become a ubiquitous...

Read More Read more about Beyond the AI Hype: How Verseon’s Physics-First Approach Challenges the Future of Drug Discovery

Boston Scientific recalibrates 2026 outlook amid sweeping global restructuring strategy

• Treatment Innovations

Boston Scientific recalibrates 2026 outlook amid sweeping global restructuring strategy

Jia Lissa July 29, 2026

Boston Scientific, a titan in the global medical technology landscape, has found itself at a strategic crossroads....

Read More Read more about Boston Scientific recalibrates 2026 outlook amid sweeping global restructuring strategy

The New Biotech Playbook: Emerging Startups Leverage Reverse Mergers to Access Public Capital

• Treatment Innovations

The New Biotech Playbook: Emerging Startups Leverage Reverse Mergers to Access Public Capital

Dwi Wanna July 29, 2026

By Gwendolyn Wu Published July 29, 2026 In a rapidly shifting landscape for life sciences, the traditional...

Read More Read more about The New Biotech Playbook: Emerging Startups Leverage Reverse Mergers to Access Public Capital